Happy Holidays
Click to view our 2016 Holiday Card
HOME
ABOUT US
DAIICHI SANKYO
NEWS
CAREER
OPPORTUNITIES
CONTRACT MANUFACTURING
SERVICES
CONTACT US

Contract Manufacturing Services

Luitpold Pharmaceuticals, Inc. manufactures, and its subsidiary American Regent, Inc., distributes a wide range of injectable parenteral medications, including products used in pharmacy admixtures and nutrient solutions, critical care drugs, antidotes, diluents and medicinal dyes.

 

We are also a full-service contract manufacturer, providing many of these and other products to major pharmaceutical companies on a contract basis - providing fast, flexible production and cost-efficient, high-quality manufacturing services.

 

Product Capabilities

  • Current Good Manufacturing Practices (cGMP) compliant 
  • Sterile injectables, specializing in diluents 
  • Vials and ampules 
  • 0.5 mL to 100 mL fill volumes

Services Available

  • Product development 
  • Analytical development 
  • Regulatory and documentation support 
  • Raw material testing 
  • Stability testing 
  • Warehousing and distribution 
  • Labeling and packaging development 
  • Complete manufacturing records and a certification of analysis for each lot produced 
  • International capabilities

Technologies

  • Terminal sterilization 
  • Four class-100 fill lines 
  • Automated packaging 
  • Automated vision inspection system

Our products are found in many hospitals and clinics throughout the United States. Known for quality injectable medications Luitpold Pharmaceutical's reputation was earned through consistency and reliability in systems and proven procedures. Our dedicated, skilled, and experienced professionals demand perfection.

 

Please visit our contact page to request more information.


DAIICHI SANKYO NAMES NEW PRESIDENT OF US SUBSIDIARY LUITPOLD PHARMACEUTICALS, INC.

June 29, 2016 – Effective today, Ken Keller has been newly appointed as President and CEO of Luitpold Pharmaceuticals, in addition to his current position as President, Daiichi Sankyo Administrative and Commercial, Daiichi Sankyo, Inc.

With more than 25 years of experience in the pharmaceutical industry in commercial leadership and joint venture leadership, Mr. Keller will now oversee both the Daiichi Sankyo, Inc. Commercial organization and Luitpold Pharmaceuticals, Inc.

Mr. Keller joined Daiichi Sankyo, Inc. in 2014 and has also served on the Luitpold Board of Directors since 2015. He has successfully led the Daiichi Sankyo, Inc. US commercial organization as it begins its transformation to a specialty focused company.

“While Luitpold and Daiichi Sankyo US businesses serve different customers and markets, they each bring to the table important strengths and focus that are essential to the continued success and growth of the Daiichi Sankyo Group,” said Ken Keller. “I look forward to working with the Luitpold team and driving even further success in the future.”

Luitpold Pharmaceuticals, Inc. is a Daiichi Sankyo Group Company headquartered in Shirley, NY, and manufactures more than 80 pharmaceutical products.